Advertisement
Screener

LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum

2.8 / 5 stars · 68/120 Roast Me

LIGAND PHARMACEUTICALS INCORPORATED Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum

LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum of 50.00% for the 12-month period ending 2015-12-31, per its 10-K filed 2016-11-14.

Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum · last filed 2016-11-14

  • LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for the quarter ending 2015-06-30 was 58.00%, a 13.43% decline year-over-year.
  • LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for the quarter ending 2015-03-31 was 58.00%, a 15.94% decline year-over-year.
  • LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for the quarter ending 2014-09-30 was 67.00%, a 4.29% decline year-over-year.
  • LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for the quarter ending 2014-06-30 was 67.00%, a 2.90% decline year-over-year.
  • LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2015 was 50.00%, a 19.35% decline from fiscal 2014.
  • LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2014 was 62.00%, a 10.14% decline from fiscal 2013.
  • LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2013 was 69.00%, a 0.00% change from fiscal 2012.
  • LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2012 was 69.00%, a 0.00% change from fiscal 2011.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 12 month as first filed
2015-12-3150.00%
10-K · filed 2016-11-14
2015-09-3050.00%
10-Q · filed 2015-11-09
2015-06-3058.00%
10-Q · filed 2015-08-05
58.00%
10-Q · filed 2015-08-05
2015-03-3158.00%
10-Q · filed 2015-05-11
2014-12-3162.00%
10-K · filed 2016-11-14
70.00%
10-K · filed 2014-12-01
2014-09-3067.00%
10-Q · filed 2014-10-31
68.00%
10-Q · filed 2014-10-31
2014-06-3067.00%
10-Q · filed 2015-08-05
69.00%
10-Q · filed 2015-08-05
2014-03-3169.00%
10-Q · filed 2015-05-11
2013-12-3169.00%
10-K · filed 2016-11-14
70.00%
10-K · filed 2014-02-24
2013-09-3070.00%
10-Q · filed 2014-10-31
70.00%
10-Q · filed 2014-10-31
2013-06-3069.00%
10-Q · filed 2014-08-05
69.00%
10-Q · filed 2014-08-05
2013-03-3170.00%
10-Q · filed 2014-05-07
2012-12-3169.00%
10-K · filed 2015-02-23
2012-09-3069.00%
10-Q · filed 2013-11-08
69.00%
10-Q · filed 2013-11-08
2012-06-3069.00%
10-Q · filed 2013-08-01
69.00%
10-Q · filed 2013-08-01
2012-03-3168.00%
10-Q · filed 2013-05-08
2011-12-3169.00%
10-K/A · filed 2014-12-12
2011-09-3068.00%
10-Q · filed 2012-11-14
69.00%
10-Q · filed 2012-11-14
2011-06-3068.00%
10-Q/A · filed 2012-11-14
69.00%
10-Q/A · filed 2012-11-14
2010-12-3172.00%
10-K · filed 2013-03-14